The end of the line? A case of drug resistance to third-line antiretroviral therapy

Tekijä Rossouw, Theresa M., Hitchcock, Sonia, Botes, Mariëtte
Julkaisussa South Afr J HIV Med (2016)

Clinical and Pharmacogenetic Factors Affecting Neonatal Bilirubinemia Following Atazanavir Treatment of Mothers During Pregnancy

Tekijä Eley, Timothy, Huang, Shu-Pang, Conradie, Francesca, Zorrilla, Carmen D., Josipovic, Deirdre, Botes, Mariëtte, Osiyemi, Olayemi, Hardy, Hélène, Bertz, Richard, McGrath, Donnie
Julkaistu 2013

Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings

Tekijä Cooper, David A., Heera, Jayvant, Ive, Prudence, Botes, Mariette, Dejesus, Edwin, Burnside, Robert, Clumeck, Nathan, Walmsley, Sharon, Lazzarin, Adriano, Mukwaya, Geoffrey, Saag, Michael, van Der Ryst, Elna
Julkaistu 2014

Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance—HIV drug resistance in sub-Saharan Africa and the Asia-Paci...

Tekijä Hamers, Raph L, Oyomopito, Rebecca, Kityo, Cissy, Phanuphak, Praphan, Siwale, Margaret, Sungkanuparph, Somnuek, Conradie, Francesca, Kumarasamy, Nagalingeswaran, Botes, Mariette E, Sirisanthana, Thira, Abdallah, Saade, Li, Patrick C K, Ngorima, Nicoletta, Kantipong, Pacharee, Osibogun, Akin, Lee, Christopher K C, Stevens, Wendy S, Kamarulzaman, Adeeba, Derdelinckx, Inge, Chen, Yi-Ming Arthur, Schuurman, Rob, van Vugt, Michèle, Rinke de Wit, Tobias F
Julkaistu 2012